Tableaux’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$660K Sell
27,256
-3,050
-10% -$73.8K 0.28% 52
2026
Q1
$735K Buy
30,306
+10,271
+51% +$249K 0.36% 47
2025
Q4
$486K Sell
20,035
-1,647
-8% -$40K 0.34% 50
2025
Q3
$528K Buy
21,682
+1,103
+5% +$26.7K 0.21% 59
2025
Q2
$499K Buy
20,579
+4,523
+28% +$109K 0.29% 56
2025
Q1
$388K Buy
+16,056
New +$386K 0.28% 55

Other funds holding IBDS

Tableaux's IBDS Position: Q2 2026 in Review

Tableaux reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 10% in Q2 2026, selling an estimated $73.8K and leaving 27,256 shares worth $660K. The position accounts for 0.28% of the portfolio, ranked #52.

Tableaux first reported a position in IBDS in Q1 2025 and has held it in 6 quarters since. The position peaked at $735K in Q1 2026. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Tableaux held 27,256 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $660K as of Q2 2026.
  • Tableaux sold 3,050 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $73.8K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.28% of Tableaux's portfolio in Q2 2026, its #52 holding.
  • Tableaux first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2025 and has held it in 6 quarters since.
  • Tableaux's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $735K in Q1 2026.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Tableaux's 13F filing for Q2 2026, filed 7 Aug 2026.